Table 8.
Clinical differences between patients with and without muscle wasting.
| Total |
Men |
Women |
||||
|---|---|---|---|---|---|---|
| Muscle wasting (-) | Muscle wasting (+) | Muscle wasting (-) | Muscle wasting (+) | Muscle wasting (-) | Muscle wasting (+) | |
| n = 63 | n = 36 | n = 43 | n = 20 | n = 19 | n = 17 | |
| Age, years |
65.6 (12.9) | 73.8 (10.2)*** | 64.5 (13.9) |
71.7 (11.9)* |
68.0 (10.0) | 76.3 (7.3)** |
| BMI, kg/m2 |
25.4 (4.0) | 22.8 (3.1)** | 25.5 (4.3) |
21.9 (2.6)** |
25.2 (3.4) | 23.9 (83.4) |
| BNP, pg/mL |
188.2 (203.4) | 560.8 (723.6)*** | 214.6 (229.8) |
686.6 (870.9)** |
128.4 (107.1) | 412.9 (484.2)* |
| eGFR, mL/min/1.73 m2 | 64.2 (22.1) | 49.9 (28.0)** | 63.1(26.4) | 44.91(29.5)* | 66.8 (16.1) | 55.8 (25.6) |
| TC, μmol/L | 62.3 (17.2) | 75.2 (46.8) | 62.7 (15.4) | 88.0 (58.8) | 61.2 (21.2) | 59.2 (15.9) |
| FC, μmol/L | 48.2 (14.6) | 54.4 (31.7) | 48.4 (12.8) | 62.3(40.1) | 47.7 (18.5) | 44.7 (11.0) |
| AC, μmol/L | 14.1 (4.6) | 20.8 (16.3) | 14.3 (4.9) | 25.7 (19.7)* | 13.5 (4.0) | 14.6 (7.6) |
| AC/FC | 0.30 (0.09) | 0.38 (0.17)* | 0.30 (0.09) | 0.42 (0.16)*** | 0.29 (0.08) | 0.34 (0.17) |
Data are shown as mean (SD). * p < 0.05, ** p < 0.01, *** p < 0.001. BMI, body mass index; BNP, brain natriuretic peptide; eGFR, estimated glomerular filtration rate; TC, total carnitine; FC, free carnitine; AC, acylcarnitine; AC/FC, the acylcarnitine/free carnitine ratio.